Epigenomics of ovarian cancer and its chemoprevention
Ovarian cancer is a major cause of death among gynecological cancers and its etiology is still unclear. Currently, the two principle obstacles in treating this life threatening disease are lack of effective biomarkers for early detection and drug resistance after initial chemotherapy. Similar to oth...
Main Authors: | Huaping eChen, Tabitha M. Hardy, Trygve eTollefsbol |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2011.00067/full |
Similar Items
-
Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
by: Sandra Muñoz-Galván, et al.
Published: (2021-08-01) -
Chemoprevention of oral cancer
by: Yogesh Chhaparwal, et al.
Published: (2012-01-01) -
The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin
by: Ching-Shu Lai, et al.
Published: (2020-05-01) -
Editorial: Epigenomic drivers of cancer disparities
by: Luciane R. Cavalli, et al.
Published: (2024-04-01) -
Cancer Chemoprevention by Carotenoids
by: Takuji Tanaka, et al.
Published: (2012-03-01)